Clinical Trials Directory

Trials / Unknown

UnknownNCT04332705

Cryptosporidium Infection and Human Colorectal Cancer

Role of the Protozoa Cryptosporidium in the Development of Colorectal Cancer in Humans

Status
Unknown
Phase
Study type
Observational
Enrollment
324 (estimated)
Sponsor
Lille Catholic University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

It has been reported that Cryptosporidium parvum, a species of a protozoan frequently isolated from humans and animals, is able to induce digestive adenocarcinoma in a rodent model. Consistently, some epidemiological studies have reported an association with cryptosporidiosis in patients with colorectal adenocarcinoma. However, the correlation between cryptosporidiosis and human digestive cancer remains unclear at this time, and it is not known whether this intracellular parasite, considered an opportunistic agent, is able to induce gastrointestinal malignancies in humans. In order to add new arguments for a probable association between cryptosporidiosis and digestive human cancer, the main aim of this study is to determine prevalence and to identify species of Cryptosporidium among a French digestive cancer population.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDetection of Cryptosporidium infectionA biopsy or a surgical sample will be collected from every participant

Timeline

Start date
2020-06-30
Primary completion
2024-06-30
Completion
2024-12-30
First posted
2020-04-03
Last updated
2023-11-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04332705. Inclusion in this directory is not an endorsement.